An immunochromatographic assay for rapid etection of salvinorin A

References

• Ortega, A.; Blount, J.F.; Manchand, Salvinorin, A New Trans-neoclerodane Diterpene from Salvia Divinorum (Labiatae). P.S. J. Chem. Soc., Perkin Trans.1 1982, 2505−2508.
   Google Scholar
• Siebert, D.J.J. Salvia Divinorum and Salvinorin A: New Pharmacologic Findings Ethnopharmacology 1994, 43, 53−56.
   PubMed Web of Science ®Google Scholar
• Roth, B.L.; Baner, K.; Westkaemper, R.; Siebert, D.; Rice, K.C.; Steinberg, S.; Ernsberger, P.; Rothman, R.B. Salvinorin A: A Potent Naturally Occurring Nonnitrogenous κ Opioid Selective Agonist. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 11934−11939.
   PubMed Web of Science ®Google Scholar
• Sheffler, D. J. Salvinorin A: The ‘Magic Mint’ Hallucinogen Finds a Molecular Target in the Kappa Opioid Receptor. Trends Pharmacol. Sci. 2003, 24, 107−109.
   PubMed Web of Science ®Google Scholar
• Valdes, L.J.; Chang, H.M.; Visger, D.S.; Koreeda, M. Salvinorin C, A New Neoclerodane Diterpene from a Bioactive Fraction of the Hallucinogenic Mexican Mint Salvia Divinorum. Org. Lett. 2001, 3, 3935−3937.
   PubMed Web of Science ®Google Scholar
• Munro, T.A.; Rizzacasa, M.A. Salvinorins D-F, New Neoclerodane Diterpenoids from Salvia Divinorum, and an Improved Method for the Isolation of Salvinorin A. J. Nat. Prod. 2003, 66, 703−705.
   PubMed Web of Science ®Google Scholar
• Vortherms, T.A.; Roth, B.L. Salvinorin A: From Natural Product to Human Therapeutics. Mol. Intervent. 2006, 6, 257−265.
   PubMed Web of Science ®Google Scholar
• Scheerer, J.R.; Lawrence, J.F.; Wang, G.C.; Evans, D.A. Asymmetric Synthesis of Salvinorin A, A Potent κ Opioid Receptor Agonist. J. Am. Chem. Soc. 2007, 129, 8968−8969.
   PubMed Web of Science ®Google Scholar
• Yang, L.; Xu, W.; Chen, F.; Liu-Chen, L.Y.; Ma, Z.Z.; Lee, D.Y.W. Synthesis and Biological Evaluation of C-12 Triazole and Oxadiazole Analogs of Salvinorin A. Bioorg. Med. Chem. Lett. 2009, 19, 1301−1304.
   PubMed Web of Science ®Google Scholar
• Hagiwara, H.; Suka, Y.; Nojima, T.; Hoshi, T.; Suzuki, T. Second-generation Synthesis of Salvinorin A. Tetrahedron 2009, 65, 4820−4825.
   Web of Science ®Google Scholar
• Yan, F.; Bikbulatov, R.V.; Mocanu, V.; Dicheva, N.; Parker, C.E.; Wetsel, W.C.; Mosier, P.D.; Westkaemper, R.B.; Allen, J.A.; Zjawiony, J.K.; Roth, B.L. Synthesis and Biological Evaluation of C-12 Triazole and Oxadiazole Analogs of Salvinorin. Biochemisty 2009, 48, 6898−6908.
   PubMed Web of Science ®Google Scholar
• Lee, D.Y.W.; Yang, L.; Xu, W.; Deng, G.; Guo, L.; Liu-Chen, L.Y. Synthesis and Biological Evaluation of C-2 Halogenated Analogs of Salvinorin A. Bioorg. Med. Chem. Lett. 2009, 20, 5749−5752.
   Web of Science ®Google Scholar
• Lozama, A.; Cunningham, C.W.; Caspers, M.J.; Douglas, J.T.; Dersch, C.M.; Rothman, R.B.; Prisinzano, T.E.J. Opioid Receptor Probes Derived from Cycloaddition of the Hallucinogen Natural Product Salvinorin A. Nat. Prod. 2011, 74, 718−726.
   PubMed Web of Science ®Google Scholar
• Fichna, J.; Lewellyn, K.; Yan, F.; Roth, B.L.; Zjawiony, J.K. Synthesis and Biological Evaluation of New Salvinorin A Analogues Incorporating Natural Amino Acids. Bioorg. Med. Chem. Lett. 2011, 21, 160−163.
   PubMed Web of Science ®Google Scholar
• Chartoff, E.H.; Potter, D.; Damez-Werno, D.; Cohen, B.M.; Carlezon, Jr., W.A. Exposure to the Selective κ-Opioid Receptor Agonist Salvinorin A Modulates the Behavioral and Molecular Effects of Cocaine in Rats. Neuropsychopharmacology 2008, 33, 2676−2687.
   Google Scholar
• Braida, D.; Capurro, V.; Zani, A.; Rubino, T.; Viganò, D.; Parolaro, D.; Sal A, M. Br. Potential Anxiolytic- and Antidepressant-like Effects of Salvinorin A, the Main Active Ingredient of Salvia Divinorum, in Rodents. J. Pharmacol. 2009, 157, 844−853.
   Google Scholar
• McCurdy, C.R.; Sufka, K.J.; Smith, G.H.; Warnick, J.E.; Nieto, M. Antinociceptive Profile of Salvinorin A, a Structurally Unique Kappa Opioid Receptor Agonist. J. Pharmacol. Biochem. Behav. 2006, 83, 109−113.
   PubMed Web of Science ®Google Scholar
• Capasso, R.; Borrelli, F.; Cascio, M.G.; Aviello, G.; Huben, K.; Zjawiony, J.K.; Marini, P.; Romano, B.; Di Marzo, V.; Capasso, F.; Izzo, A.A.Br. Inhibitory Effect of Salvinorin A, from Salvia Divinorum, on Ileitis-induced Hypermotility: Cross-talk between κ-opioid and Cannabinoid CB1 Receptors. J. Pharmacol. 2008, 155, 681−689.
   Google Scholar
• Pichini, S.; Abanades, S.; Farre, M.; Pellegrini, M.; Marchei, E.; Pacifici, R.; de la Torre, R.; Zuccaro, P. Quantification of the Plant-derived Hallucinogen Salvinorin A in Conventional and Non-conventional Biological Fluids by Gas Chromatography/Mass Spectrometry after Salvia Divinorum Smoking. Rapid Commun. Mass Spectrom. 2005, 19, 1649−1656.
   PubMed Web of Science ®Google Scholar
• Kennedy, J.H.; Wiseman, J.M. Direct Analysis of Salvia Divinorum Leaves for Salvinorin A by Thin Layer Chromatography and Desorption Electrospray Ionization Multi-stage Tandem Mass Spectrometry. Rapid Commun. Mass Spectrom. 2010, 24, 1305−1311.
   PubMed Web of Science ®Google Scholar
• Jermain, J.D.; Evans, H.K. Analyzing Salvia Divinorum and its Active Ingredient Salvinorin A Utilizing Thin Layer Chromatography and Gas Chromatography/Mass Spectrometry. J. Forensic Sci. 2009, 54, 612−616.
   PubMed Web of Science ®Google Scholar
• Schimidt, M.S.; Prisinzano, T.E.; Tidgewell, K.; Harding, W.; Kreek, M.J.; Murry, D.J. Determination of Salvinorin A in Body Fluids by High Performance Liquid Chromatography-atmospheric Pressure Chemical Ionization. J. Chromatogr. B 2005, 818, 221−225.
   Google Scholar
• Tsujikawa, K.; Kuwayama, K.; Miyaguchi, H.; Kanamori, T.; Iwata, Y.T.; Yoshida, T.; Inoue, H. Determination of Salvinorin A and Salvinorin B in Salvia Divinorum-related Products Circulated in Japan. Forensic Sci. Int. 2008, 180, 105−109.
   PubMed Web of Science ®Google Scholar
• Shoyama, Y.; Fukada, T.; Tanaka, T.; Kusai, A.; Nojima, K. Direct Determination of Opium Alkaloid-bovine Serum Albumin Conjugate by Matrix-assisted Laser Desorption/Ionization Mass Spectrometry. Biol. Pharm. Bull. 1993, 16, 1051−1053.
   PubMed Web of Science ®Google Scholar
• Tanaka, H.; Goto, Y.; Shoyama, Y. Monoclonal Antibody based Enzyme Immunoassay for Marijuana (Cannabinoid) Compounds. J. Immunoassay 1996, 17, 321−342.
   PubMedGoogle Scholar
• Yanagihara, H.; Sakata, R.; Minami, H.; Tanaka, H.; Shoyama, Y.; Murakami, H. Immunoaffinity Column Chromatography against Forskolin Using an Anti-forskolin Monoclonal Antibody and its Application. Anal. Chim. Acta 1996, 335, 63−70.
   Web of Science ®Google Scholar
• Shan, S.J.; Tanaka, H.; Shoyama, Y. Enzyme-linked Immunosorbent Assay for Glycyrrhizin using Anti-glycyrrhizin Monoclonal Antibody and an Eastern Blotting Technique for Glucuronides of Glycyrrhetic Acid. Anal. Chem. 2001, 73, 5784−5790.
   PubMed Web of Science ®Google Scholar
• Kim, J.S.; Tanaka, H.; Shoyama, Y. Immunoquantitative Analysis for Berberine and its Related Compounds using Monoclonal Antibodies in Herbal Medicines. Analyst 2004, 129, 87−91.
   PubMed Web of Science ®Google Scholar
• Phrompittayarat, W.; Putalun, W.; Tanaka, H.; Wittaya-Areekul, S.; Jetiyanon, K.; Ingkaninan, K. An Enzyme-linked Immunosorbent Assay using Polyclonal Antibodies against Bacopaside. Anal. Chim. Acta 2007, 584, 1−6.
   PubMed Web of Science ®Google Scholar
• Sakamoto, S.; Putalun, W.; Tsuchihashi, R.; Morimoto, S.; Kinjo,J.; Tanaka, H. Development of an Enzyme-linked Immunosorbent Assay (ELISA) using Highly-specific Monoclonal Antibodies against Plumbagin. Anal. Chim. Acta 2008, 607, 100−105.
   PubMed Web of Science ®Google Scholar
• Kido, K.; Edakuni, K.; Morinaga, O.; Tanaka, H.; Shoyama, Y. An Enzyme-linked Immunosorbent Assay for Aconitine-type Alkaloids using an Anti-aconitine Monoclonal Antibody. Anal. Chim. Acta 2008, 616, 109−114.
   PubMed Web of Science ®Google Scholar
• Juengwatanatrakul, T.; Sritularak, B.; Amornnopparattanakul, P.; Tassanawat, P.; Putalun, W.; Tanaka, H.; Morimoto, S. Preparation of a Specific Monoclonal Antibody to Asiaticoside for the Development of an Enzyme-linked Immunosorbent Assay. Analyst 2011, 136, 1013−1017.
   PubMed Web of Science ®Google Scholar
• Kido, K.; Morinaga, O.; Shoyama, Y.; Tanaka, H. Quick Analysis of Baicalin in Scutellariae Radix by Enzyme-linked Immunosorbent Assay using a Monoclonal Antibody. Talanta 2008, 77, 346−350.
   PubMed Web of Science ®Google Scholar
• Paudel, M.K.; Putalun, W.; Sritularak, B.; Morinaga, O.; Shoyama, Y.; Tanaka, H.; Morimoto, S. Development of a Combined Technique using a Rapid One-step Immunochromatographic Assay and Indirect Competitive ELISA for the Rapid Detection of Baicalin. Anal. Chim. Acta 2011, 701, 189−193.
   PubMed Web of Science ®Google Scholar
• Paudel, M.K., Shirota, O, Sasaki-Tabata, K.; Tanaka, H.; Sekita, S.; Morimoto, S. Development of an Enzyme Immunoassay using a Monoclonal Antibody against the Psychoactive Diterpenoid Salvinorin A. J. Nat. Product. 2013, 76(9), 1654–1660.
   PubMed Web of Science ®Google Scholar
• Gruber, J.W.; Siebert, D.J.; Der Marderosian, A.H.; Hock, R.S. High Performance Liquid Chromatographic Quantification of Salvinorin A from Tissues of Salvia Divinorum Epling & Jativa-M. Phytochem. Anal. 1999, 10, 22−25.
   Web of Science ®Google Scholar
• Shirota, O.; Nagamatsu, K.; Sekita, S. Neo-clerodane Diterpenes from the Hallucinogenic Sage Salvia Divinorum. J. Nat. Prod. 2006, 69, 1782−1786.
   PubMed Web of Science ®Google Scholar
• Beguin, C.; Richards, M.R.; Wang, Y.; Chen, Y.; Liu-Chen, L.Y.; Ma, Z.; Lee, D.Y.W.; Carlezon, W.A.; Cohen, B.M. Synthesis and in vitro Pharmacological Evaluation of Salvinorin A Analogues Modified at C(2). Bioorg. Med. Chem. Lett. 2005, 15, 2761−2765.
   PubMed Web of Science ®Google Scholar
• Beguin, C.; Richards, M.R.; Li, J.-G.; Wang, Y.; Xu, W.; Liu-Chen, L.Y.; Carlezon, W.A.; Cohen, B.M. Synthesis and in vitro Evaluation of Salvinorin A Analogues: Effect of Configuration at C (2) and Substitution at C (18). Bioorg. Med. Chem. Lett. 2006, 16, 4679−4685.
   PubMed Web of Science ®Google Scholar